FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Wednesday

 

Multiple Sclerosis project targets earlier detection
























Albertans with multiple sclerosis are hoping a research project at the University of Alberta will lead to earlier detection and better treatment of the disease.

“Having this research done right here in Alberta is quite significant and exciting because MS is a terrible disease,” said Julie Kelendorfer, an MS patient who works with the MS Society.

The $1.4 million Multiple Sclerosis Experimental Therapeutics Program is looking at ways to detect and diagnose multiple sclerosis earlier in patients.

It will also try to develop therapies to halt and even reverse some of the symptoms in people living with the disease.

“It's a difficult disease to live with and so any support and research is imperative to people feeling hopeful,” Kelendorfer said.

The project will be funded by the province and Biogen Idec, an U.S.-based biotechnology company.

Canada has one of the highest rates of multiple sclerosis in the world. About 14,000 Albertans live with MS.

Story Source: The above story is based on materials provided by CBCNEWS
Note: Materials may be edited for content and length


Go to Newer News Go to Older News